We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

84 hedge funds and large institutions have $31.7M invested in Tempest Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

5% more funds holding

Funds holding: 80 → 84 (+4)

85% less capital invested

Capital invested by funds: $206M → $31.7M (-$175M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $38K

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
13
Closed
16
Calls
–
Puts
$38K
Net Calls
-$38K
Net Calls Change
+$49K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$1.77M
2
Millennium Management
Millennium Management
New York
+$1.57M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$1.32M
4
Morgan Stanley
Morgan Stanley
New York
+$473K
5
AIC
AWM Investment Company
New York
+$424K

Top Sellers

Rank Fund Capital Flow
1
OAG
Orbis Allan Gray
Bermuda
-$18.9M
2
JHIU
Janus Henderson Investors US
Colorado
-$16.4M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$12.1M
4
Jennison Associates
Jennison Associates
New York
-$3.31M
5
Asset Management One
Asset Management One
Japan
-$2.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$8.17M +$287K +23 +1%
Jennison Associates
2
Jennison Associates
New York
$3.34M -$3.31M -266 -26%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2M +$424K +34 +8%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$1.96M -$1.99M -160 -27%
BFA
5
BlackRock Fund Advisors
California
$1.57M -$1.36M -109 -24%
BIT
6
BlackRock Institutional Trust
California
$1.05M – – –
CC
7
CQS Cayman
Cayman Islands
$1.05M – – –
PCM
8
Portolan Capital Management
Massachusetts
$1.02M -$847K -68 -23%
Franklin Resources
9
Franklin Resources
California
$973K – – –
Northern Trust
10
Northern Trust
Illinois
$813K +$24.9K +2 +1%
GC
11
GMT Capital
Georgia
$807K +$411K +33 +22%
State Street
12
State Street
Massachusetts
$731K +$199K +16 +11%
AFM
13
Anson Funds Management
Texas
$637K +$1.77M +142 New
TS
14
Third Security
Virginia
$571K – – –
Millennium Management
15
Millennium Management
New York
$565K +$1.57M +126 New
Tudor Investment Corp
16
Tudor Investment Corp
Connecticut
$519K +$1.32M +106 +1,060%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$420K +$299K +24 +34%
BCM
18
BBT Capital Management
Texas
$388K – – –
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$354K +$262K +21 +36%
BCM
20
Bridgeway Capital Management
Texas
$282K +$424K +34 +117%
Wells Fargo
21
Wells Fargo
California
$260K +$361K +29 +100%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$251K +$87.2K +7 +14%
Morgan Stanley
23
Morgan Stanley
New York
$239K +$473K +38 +253%
AIC
24
AWM Investment Company
New York
$229K +$424K +34 +200%
BIM
25
BlackRock Investment Management
Delaware
$200K – – –
1
2 3 4 5

TPST Hedge Fund Activity: Q4 2016 in Review

84 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2016, worth a combined $31.7M — down 85% from $206M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TPST positions and 16 closed out — a net gain of 4 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.77M. The largest seller was Orbis Allan Gray, exiting entirely with an estimated $18.9M sold.

  • 84 institutional investors held Tempest Therapeutics (TPST) as of Q4 2016, up from 80 in Q3 2016.
  • Funds reported $31.7M of Tempest Therapeutics stock for Q4 2016, down 85% quarter-over-quarter.
  • 20 funds opened new Tempest Therapeutics positions in Q4 2016 and 16 closed out, a net change of +4 holders.
  • The largest Tempest Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $1.77M added.
  • The largest Tempest Therapeutics seller in Q4 2016 was Orbis Allan Gray, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2016.